ERS Congress, Vienna, 15 September 2009, 13:00-14:00

Aims: Knowledge on project activities:

1. epidemiological and molecular analysis;

2. basic and clinical research on multidrug resistant tuberculosis (MDR-TB) (development of drug-resistances; characterisation of virulence features; further insight into novel diagnostic/risk factors); and

3. training on MDR-TB.

- Knowledge on expected impact of the project

- Future collaborations/networks

Target audience: Molecular biologists, mycobacteriologists, infectious diseases specialists, pneumologists, epidemiologists and international public health experts in TB control programmes.

13:00 TB-PANNET an integrated approach for controlling MDR-TB spread in Europe
F. Drobniewski (London, United Kingdom)

13:30 Open discussion: questions & answers